Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)
13.54
-0.07 (-0.51%)
Nov 17, 2026, 3:04 PM CST
SHE:300122 Revenue
Chongqing Zhifei Biological Products had revenue of 2.51B CNY in the quarter ending September 30, 2026, a decrease of -7.40%. This brings the company's total for the last twelve months to 7.85B, down -28.00% year-over-year. In the year 2025, Chongqing Zhifei Biological Products had annual revenue of 8.96B, down -65.61%. That makes Chongqing Zhifei Biological Products the 6,935th largest company in the world by revenue and 989th in China.
Revenue (ttm)
7.85B
Revenue Growth
-28.00%
P/S Ratio
4.15
Revenue / Employee
1.25M
Employees
6,292
Market Cap
32.41B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full SHE:300122 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.96B | -17.09B | -65.61% |
| Dec 31, 2024 | 26.05B | -26.87B | -50.77% |
| Dec 31, 2023 | 52.92B | 14.65B | 38.30% |
| Jan 1, 2023 | 38.26B | 7.61B | 24.83% |
| Dec 31, 2021 | 30.65B | 15.46B | 101.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
Revenue RankingsChongqing Zhifei Biological Products News
- 21 days ago - Chongqing Zhifei Biological Products Quarterly report: Q3 2026 - Filings
- 2 months ago - Chongqing Zhifei Biological Products Quarterly report: Q2 2026 - Filings
- 6 months ago - Chongqing Zhifei Biological Products Annual report: Q4 2025 - Filings
- 6 months ago - Chongqing Zhifei Biological Products Quarterly report: Q1 2026 - Filings